Abiomed ประกาศผู้ป่วยรายแรกที่เข้าร่วมการศึกษาวิจัยความเป็นไปได้ STEMI DTU
05. Mai 2017 14:00 ET
|
Abiomed
DANVERS, Mass., May 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD)...
아비오메드 STEMI DTU 타당성 연구에 첫 환자 등록
05. Mai 2017 14:00 ET
|
Abiomed
미국 매사추세츠주 댄버스, May 06, 2017 (GLOBE NEWSWIRE) -- 획기적인 심장보조기술 업체 아비오메드(Abiomed, Inc.) (NASDAQ:ABMD)가 FDA 승인을 받은 전향적 타당성 연구에 첫 실험 환자가 등록했다고 발표했다. 이 연구는 급성심근경색 단계에서 Impella CP® 시스템을 이용한 STEMI DTU(Door...
Abiomed 宣佈STEMI DTU可行性研究 已招募到首位患者
05. Mai 2017 14:00 ET
|
Abiomed
美國麻塞諸塞州丹佛斯市, May 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc.（納斯達克代碼：ABMD）是一家領先的突破性心臟支支援術提供商，今天宣佈美國食品藥品監管局（FDA）批准的一項前瞻性可行性研究已招募到首位患者。這項研究名為「STEMI從門到卸荷（DTU）」，是對急性心肌梗死患者使用Impella...
Abiomed Mengumumkan Pasien Pertama yang Mengikuti Studi Kelayakan STEMI DTU
05. Mai 2017 14:00 ET
|
Abiomed
DANVERS, Mass., May 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), penyedia teknologi terobosan dukungan jantung terkemuka, hari ini mengumumkan pasien pertama yang mengikuti studi...
Abiomed Mengumumkan Pesakit Pertama yang Mendaftar dalam Kajian Kemungkinan STEMI DTU
05. Mai 2017 14:00 ET
|
Abiomed
DANVERS, Mass, May 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), pembekal terkemuka bagi kejayaan teknologi sokongan hati, hari ini mengumumkan pendaftaran pesakit pertama dalam Food...
Abiomed anuncia el primer paciente inscrito en el estudio de viabilidad de STEMI DTU
05. Mai 2017 14:00 ET
|
Abiomed
DANVERS, Massachusetts, May 05, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), un proveedor líder de tecnologías innovadoras para asistencia cardíaca, anunció hoy la inscripción del...
Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study
04. Mai 2017 07:01 ET
|
Abiomed
DANVERS, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announced today the enrollment of the first patient in...
Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year
04. Mai 2017 07:00 ET
|
Abiomed
DANVERS, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2017 revenue of...
Abiomed Fourth Quarter Fiscal 2017 Earnings and Conference Call Notification
13. April 2017 08:00 ET
|
Abiomed
DANVERS, Mass., April 13, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, May 4, 2017, the Company will release financial results for the fourth quarter of fiscal...
Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts
30. März 2017 12:26 ET
|
Abiomed
DANVERS, Mass., March 30, 2017 (GLOBE NEWSWIRE) -- Massachusetts Governor Charlie Baker today joined Abiomed – a leading provider of breakthrough heart support and recovery technologies – for the...